| Matthew Allen Mckee, MD | |
|
7500 Challis Rd, Brighton, MI 48116-9416 | |
| (810) 263-4000 | |
| Not Available |
| Full Name | Matthew Allen Mckee |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 7500 Challis Rd, Brighton, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326205089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301091876 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
A rare, deadly form of skin cancer known as desmoplasmic melanoma (DM) may possess the highest burden of gene mutations of any cancer, suggesting that immunotherapy may be a promising approach for treatment, according to an international team led by UC San Francisco scientists. One of these mutations, never before observed in any cancer, may shield nascent DM tumors from destruction by the immune system and allow further mutations to develop.
Researchers at the UW Medicine, Veteran's Administration Puget Sound and Saint Louis University have made a promising discovery that insulin delivered high up in the nasal cavity goes to affected areas of brain with lasting results in improving memory.
A new report from Medscape finds that more than 1 in 10 female physicians and 16% of female residents have experienced sexual harassment within the past three years. Overall, 7% of physicians (12% women, 4% men), and 9% of medical residents (16% women, 4% men) reported harassment.
U.S. researchers who collaborate with international scientists are more likely to have their work cited than peers who do not utilize overseas expertise, according to a new study released this week by Rice University's Baker Institute for Public Policy.
OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.
› Verified 3 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568495299 PECOS PAC ID: 3779496856 Enrollment ID: O20031118000092 |
News Archive
A rare, deadly form of skin cancer known as desmoplasmic melanoma (DM) may possess the highest burden of gene mutations of any cancer, suggesting that immunotherapy may be a promising approach for treatment, according to an international team led by UC San Francisco scientists. One of these mutations, never before observed in any cancer, may shield nascent DM tumors from destruction by the immune system and allow further mutations to develop.
Researchers at the UW Medicine, Veteran's Administration Puget Sound and Saint Louis University have made a promising discovery that insulin delivered high up in the nasal cavity goes to affected areas of brain with lasting results in improving memory.
A new report from Medscape finds that more than 1 in 10 female physicians and 16% of female residents have experienced sexual harassment within the past three years. Overall, 7% of physicians (12% women, 4% men), and 9% of medical residents (16% women, 4% men) reported harassment.
U.S. researchers who collaborate with international scientists are more likely to have their work cited than peers who do not utilize overseas expertise, according to a new study released this week by Rice University's Baker Institute for Public Policy.
OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.
› Verified 3 days ago
| Entity Name | Richard C Mertz Jr Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467408914 PECOS PAC ID: 3173562824 Enrollment ID: O20050502000837 |
News Archive
A rare, deadly form of skin cancer known as desmoplasmic melanoma (DM) may possess the highest burden of gene mutations of any cancer, suggesting that immunotherapy may be a promising approach for treatment, according to an international team led by UC San Francisco scientists. One of these mutations, never before observed in any cancer, may shield nascent DM tumors from destruction by the immune system and allow further mutations to develop.
Researchers at the UW Medicine, Veteran's Administration Puget Sound and Saint Louis University have made a promising discovery that insulin delivered high up in the nasal cavity goes to affected areas of brain with lasting results in improving memory.
A new report from Medscape finds that more than 1 in 10 female physicians and 16% of female residents have experienced sexual harassment within the past three years. Overall, 7% of physicians (12% women, 4% men), and 9% of medical residents (16% women, 4% men) reported harassment.
U.S. researchers who collaborate with international scientists are more likely to have their work cited than peers who do not utilize overseas expertise, according to a new study released this week by Rice University's Baker Institute for Public Policy.
OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Allen Mckee, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Matthew Allen Mckee, MD 7500 Challis Rd, Brighton, MI 48116-9416 Ph: (810) 263-4000 |
News Archive
A rare, deadly form of skin cancer known as desmoplasmic melanoma (DM) may possess the highest burden of gene mutations of any cancer, suggesting that immunotherapy may be a promising approach for treatment, according to an international team led by UC San Francisco scientists. One of these mutations, never before observed in any cancer, may shield nascent DM tumors from destruction by the immune system and allow further mutations to develop.
Researchers at the UW Medicine, Veteran's Administration Puget Sound and Saint Louis University have made a promising discovery that insulin delivered high up in the nasal cavity goes to affected areas of brain with lasting results in improving memory.
A new report from Medscape finds that more than 1 in 10 female physicians and 16% of female residents have experienced sexual harassment within the past three years. Overall, 7% of physicians (12% women, 4% men), and 9% of medical residents (16% women, 4% men) reported harassment.
U.S. researchers who collaborate with international scientists are more likely to have their work cited than peers who do not utilize overseas expertise, according to a new study released this week by Rice University's Baker Institute for Public Policy.
OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.
› Verified 3 days ago
Nicholas Michael Carducci, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2305 Genoa Business Park Dr Ste 250, Brighton, MI 48114 Phone: 810-494-2020 Fax: 810-494-0127 | |
Dr. Holly Stemen Holm, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10201 Grand River Rd., Brighton, MI 48116 Phone: 810-229-3363 Fax: 810-229-5532 | |
Dr. Michelle Marie Verplanck, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10201 Grand River Rd, Brighton, MI 48116 Phone: 810-229-3363 Fax: 810-229-5532 | |
Dr. Stephen M Tait, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7575 Grand River Rd Ste 111, Brighton, MI 48114 Phone: 810-844-7744 Fax: 810-844-7725 | |
Robert Thomas Clark, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7575 Grand River Rd, Ste 111, Brighton, MI 48114 Phone: 810-844-7744 Fax: 810-844-7725 | |
Emily Michelle Schehlein, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2305 Genoa Business Park Dr Ste 250, Brighton, MI 48114 Phone: 810-494-2020 |